Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cobalis
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cobalis

Cobalis

Cobalis Corp.: Specialty pharma firm developing treatments for atopic diseases and allergy prevention.

HQ
Irvine, CA, US
Founded
1997
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to develop innovative treatments for atopic diseases, Cobalis Corp. is a specialty pharmaceutical company focused on preventing and treating conditions such as allergies, migraine headaches, atopic asthma, and dermatitis. Their flagship product, PreHistin, is an allergy prevention medication currently in Phase III clinical development. Cobalis aims to secure FDA approval to market PreHistin as an over-the-counter medication in the United States.

Cobalis has garnered attention from notable investors and industry experts who recognize the potential impact of their groundbreaking work. The company's key achievements include advancing PreHistin through critical phases of clinical trials, positioning it as a promising solution for allergy sufferers. By focusing on unmet medical needs in the atopic disease market, Cobalis is poised to make significant contributions to improving patient outcomes and quality of life.

Cobalis - Similar Companies

Corbus Pharmaceuticals Holdings logo

Corbus Pharmaceuticals Holdings

corbuspharma.com

ClostraBio logo

ClostraBio

clostrabio.com

Corsair Pharma logo

Corsair Pharma

corsairpharma.com

Accuitis logo

Accuitis

accuitis.com

Stocosil logo

Stocosil

Allermi logo

Allermi

Halia Therapeutics logo

Halia Therapeutics

HI-Bio logo

HI-Bio

hibio.com

Attralus logo

Attralus

attralus.com

Collegium Pharmaceutical logo

Collegium Pharmaceutical

Cambrian BioPharma logo

Cambrian BioPharma

cambrianbio.com

Epalex logo

Epalex

epalex.com

Argentis Pharmaceuticals logo

Argentis Pharmaceuticals

argentisrx.com

Allergenis logo

Allergenis

allergenis.com

Microdermis logo

Microdermis

Cobalis - Quick Facts

Who are Cobalis' competitors?

Companies similar to Cobalis include Corbus Pharmaceuticals Holdings, ClostraBio, Corsair Pharma and Accuitis.

When was Cobalis founded?

Cobalis was founded in 1997.

Where is Cobalis' headquarters located?

Cobalis' headquarters is located in Irvine, CA, US.

When was Cobalis' last funding round?

Cobalis' most recent funding round was for $3.9M (USD) in February 2007.

How much has Cobalis raised to-date?

As of Feb 22, 2007, Cobalis has raised a total of $6.3M (USD).

How many employees does Cobalis have?

Cobalis has 6 employees as of Feb 5, 2024.

Cobalis - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 5600Apparel And Accessory Stores
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research